BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6358985)

  • 1. Immune complexes of IgG1 and IgG3 subclasses in human breast cancer sera detected by monoclonal antibodies in an indirect immunoenzymatic assay.
    Manzo C; Bianchin A; Pirozzi G; Totaro G
    Oncology; 1983; 40(6):395-9. PubMed ID: 6358985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q solid-phase enzymatic microassay for detection of circulating immune complexes: its application in human breast cancer.
    Manzo C; Longo C; Bianchin A
    Tumori; 1982 Feb; 68(1):47-52. PubMed ID: 7041380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.
    Sällberg M; Norder H; Lindh G; Magnius LO
    Clin Exp Immunol; 1991 Apr; 84(1):116-21. PubMed ID: 2015701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current situation and problems in the estimation of circulating immune complexes].
    Yoshida H
    Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A solid phase C1q enzyme assay for circulating immune complexes adapted for routine clinical laboratory testing.
    James K; Vahey A; Robinson M; Marder R
    Am J Clin Pathol; 1983 Oct; 80(4):445-52. PubMed ID: 6353904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating IgA immune complexes in patients with psoriasis.
    Hall RP; Peck GL; Lawley TJ
    J Invest Dermatol; 1983 Jun; 80(6):465-8. PubMed ID: 6602187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of complement activation by IgG4 antibodies.
    van der Zee JS; van Swieten P; Aalberse RC
    Clin Exp Immunol; 1986 May; 64(2):415-22. PubMed ID: 3488859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G subclasses in serum and circulating immune complexes in patients with Kawasaki syndrome.
    Li CR; Yang XQ; Shen J; Li YB; Jiang LP
    Pediatr Infect Dis J; 1990 Aug; 9(8):544-7. PubMed ID: 2235169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
    Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
    Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in sera of patients infected with Echinococcus granulosus.
    Pini C; Pastore R; Valesini G
    Clin Exp Immunol; 1983 Mar; 51(3):572-8. PubMed ID: 6406114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgG type test to assay circulating immune complexes from polyethylene glycol precipitates compared with C1q binding and Raji cell tests.
    Levinson SS; Goldman J
    Clin Biochem; 1984 Dec; 17(6):341-4. PubMed ID: 6335066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis.
    Baughn RE; McNeely MC; Jorizzo JL; Musher DM
    J Immunol; 1986 Feb; 136(4):1406-14. PubMed ID: 2418114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.